JP2019526550A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019526550A5 JP2019526550A5 JP2019508173A JP2019508173A JP2019526550A5 JP 2019526550 A5 JP2019526550 A5 JP 2019526550A5 JP 2019508173 A JP2019508173 A JP 2019508173A JP 2019508173 A JP2019508173 A JP 2019508173A JP 2019526550 A5 JP2019526550 A5 JP 2019526550A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- pyridin
- amino
- pyrimidin
- benzamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(*)c1nc(*)c2nc(C)[n](C(CI)I)c2n1 Chemical compound CC(*)c1nc(*)c2nc(C)[n](C(CI)I)c2n1 0.000 description 4
- IYXKCVLIKNINEL-UHFFFAOYSA-N CC#CC(N(CCC1)C1NC)=O Chemical compound CC#CC(N(CCC1)C1NC)=O IYXKCVLIKNINEL-UHFFFAOYSA-N 0.000 description 1
- ACVJPEOEZZBOHY-UHFFFAOYSA-N CC(C=CC=C1)(C=C1NC)NC(C=C)=O Chemical compound CC(C=CC=C1)(C=C1NC)NC(C=C)=O ACVJPEOEZZBOHY-UHFFFAOYSA-N 0.000 description 1
- JCXOKBUYQHZSEY-UHFFFAOYSA-N CN(C)C(CCC1)CN1C(C=C)=O Chemical compound CN(C)C(CCC1)CN1C(C=C)=O JCXOKBUYQHZSEY-UHFFFAOYSA-N 0.000 description 1
- FPHMTFSROQUUQU-UHFFFAOYSA-N CNC(C#CI)=O Chemical compound CNC(C#CI)=O FPHMTFSROQUUQU-UHFFFAOYSA-N 0.000 description 1
- BEQQDUWUAIDHNZ-UHFFFAOYSA-N CNC(CCC1)N1C(C=C)=O Chemical compound CNC(CCC1)N1C(C=C)=O BEQQDUWUAIDHNZ-UHFFFAOYSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022017081A JP2022058912A (ja) | 2016-08-15 | 2022-02-07 | 特定の化学的実体、組成物、および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662375382P | 2016-08-15 | 2016-08-15 | |
| US62/375,382 | 2016-08-15 | ||
| PCT/US2017/046819 WO2018035061A1 (en) | 2016-08-15 | 2017-08-14 | Certain chemical entities, compositions, and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017081A Division JP2022058912A (ja) | 2016-08-15 | 2022-02-07 | 特定の化学的実体、組成物、および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019526550A JP2019526550A (ja) | 2019-09-19 |
| JP2019526550A5 true JP2019526550A5 (enExample) | 2020-09-03 |
| JP7101165B2 JP7101165B2 (ja) | 2022-07-14 |
Family
ID=61196987
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508173A Expired - Fee Related JP7101165B2 (ja) | 2016-08-15 | 2017-08-14 | 特定の化学的実体、組成物、および方法 |
| JP2022017081A Ceased JP2022058912A (ja) | 2016-08-15 | 2022-02-07 | 特定の化学的実体、組成物、および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017081A Ceased JP2022058912A (ja) | 2016-08-15 | 2022-02-07 | 特定の化学的実体、組成物、および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10544106B2 (enExample) |
| EP (2) | EP3497087B1 (enExample) |
| JP (2) | JP7101165B2 (enExample) |
| CN (1) | CN109843858B (enExample) |
| AU (1) | AU2017312561B2 (enExample) |
| CA (1) | CA3033370A1 (enExample) |
| WO (1) | WO2018035061A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ718190A (en) | 2013-08-23 | 2017-10-27 | Neupharma Inc | Substituted quinazolines for inhibiting kinase activity |
| EP3270694A4 (en) | 2015-02-17 | 2018-09-05 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| AU2017312561B2 (en) | 2016-08-15 | 2022-06-30 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| CN110386921A (zh) * | 2018-04-23 | 2019-10-29 | 南京药捷安康生物科技有限公司 | 成纤维细胞生长因子受体抑制剂化合物 |
| US12522583B2 (en) | 2018-11-07 | 2026-01-13 | Dana-Farber Cancer Institute, Inc. | Benzimidazole derivatives and aza-benzimidazole derivatives as Janus kinase 2 inhibitors and uses thereof |
| WO2020097400A1 (en) | 2018-11-07 | 2020-05-14 | Dana-Farber Cancer Institute, Inc. | Imidazopyridine derivatives and aza-imidazopyridine derivatives as janus kinase 2 inhibitors and uses thereof |
| US12415816B2 (en) | 2018-11-07 | 2025-09-16 | Dana-Farber Cancer Institute, Inc. | Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof |
| WO2020168963A1 (zh) * | 2019-02-18 | 2020-08-27 | 深圳市塔吉瑞生物医药有限公司 | 取代的芳香稠合环衍生物及其组合物及用途 |
| KR102921974B1 (ko) * | 2019-05-31 | 2026-02-05 | 키에시 파르마슈티시 엣스. 피. 에이. | P2x3 억제제로서 아미노 퀴나졸린 유도체 |
| CN110724143B (zh) * | 2019-10-09 | 2021-03-23 | 清华大学 | 一种靶向btk蛋白降解化合物的制备及其在治疗自身免疫系统疾病与肿瘤中的应用 |
| GB201915831D0 (en) * | 2019-10-31 | 2019-12-18 | Cancer Research Tech Ltd | Compounds, compositions and therapeutic uses thereof |
| EP4061341A4 (en) * | 2019-11-22 | 2024-04-10 | The Regents of the University of California | CASPASE6 INHIBITORS AND USES THEREOF |
| WO2021102299A1 (en) * | 2019-11-22 | 2021-05-27 | The Regents Of The University Of California | Caspase 6 inhibitors and uses thereof |
| US12441707B2 (en) | 2019-12-30 | 2025-10-14 | Tyra Biosciences, Inc. | Indazole compounds |
| WO2021198981A1 (en) | 2020-04-01 | 2021-10-07 | Janssen Biopharma, Inc. | Antiviral compounds and uses thereof |
| TW202204350A (zh) | 2020-05-06 | 2022-02-01 | 美商雅捷可斯治療公司 | 作為ｊａｋ２抑制劑之６－雜芳基氧基苯并咪唑及氮雜苯并咪唑 |
| CN115916759B (zh) * | 2020-06-19 | 2025-07-15 | 泰州红云制药有限公司 | 取代喹唑啉类化合物、其制备方法、药物组合及应用 |
| CN115836070B (zh) * | 2020-08-10 | 2024-08-09 | 上海和誉生物医药科技有限公司 | 作为egfr抑制剂的稠环化合物及其制备方法和应用 |
| US20230391779A1 (en) * | 2020-08-17 | 2023-12-07 | Betta Pharmaceuticals Co., Ltd. | Bicyclic compounds, compositions and use thereof |
| WO2022053000A1 (zh) * | 2020-09-10 | 2022-03-17 | 四川海思科制药有限公司 | 一种碳环酰胺衍生物及其在医药上的应用 |
| US12115154B2 (en) | 2020-12-16 | 2024-10-15 | Srx Cardio, Llc | Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) |
| US20240100172A1 (en) | 2020-12-21 | 2024-03-28 | Hangzhou Jijing Pharmaceutical Technology Limited | Methods and compounds for targeted autophagy |
| US12043632B2 (en) | 2020-12-23 | 2024-07-23 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors |
| CN113603695B (zh) * | 2021-08-05 | 2022-06-14 | 青岛恒宁生物科技有限公司 | 一种取代的嘧啶胺类化合物或其作为农药可接受的盐、组合物及其用途 |
| WO2023086320A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | Forms and compositions of inhibitors of jak2 |
| CA3234638A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| CN119841806A (zh) * | 2023-10-16 | 2025-04-18 | 中国医学科学院药物研究所 | 多取代的喹唑啉类化合物及其制备方法、用途和药物组合物 |
| WO2025212165A1 (en) * | 2024-04-05 | 2025-10-09 | Board Of Regents Of The University Of Nebraska | Targeted heterobifunctional small molecule proteolysis targeting chimeras |
| WO2025235874A1 (en) * | 2024-05-10 | 2025-11-13 | Schrödinger, Inc. | Heterocyclics as egfr inhibitors |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB587936A (en) | 1944-09-05 | 1947-05-09 | Francis Henry Swinden Curd | New quinazoline derivatives |
| GB8515934D0 (en) * | 1985-06-24 | 1985-07-24 | Janssen Pharmaceutica Nv | (4-piperidinomethyl and-hetero)purines |
| US5033252A (en) | 1987-12-23 | 1991-07-23 | Entravision, Inc. | Method of packaging and sterilizing a pharmaceutical product |
| US5052558A (en) | 1987-12-23 | 1991-10-01 | Entravision, Inc. | Packaged pharmaceutical product |
| US5323907A (en) | 1992-06-23 | 1994-06-28 | Multi-Comp, Inc. | Child resistant package assembly for dispensing pharmaceutical medications |
| ES2293638T3 (es) | 1994-03-25 | 2008-03-16 | Isotechnika, Inc. | Mejora de la eficacia de farmacos por deuteracion. |
| US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| KR19990082488A (ko) | 1996-02-12 | 1999-11-25 | 루트거스, 더 스테이트 유니버시티 오브 뉴 저지 | 토포이소머라제 억제제로서의 코르알린 동족체 |
| JP4471404B2 (ja) | 1996-02-13 | 2010-06-02 | アストラゼネカ ユーケイ リミテッド | Ｖｅｇｆインヒビターとしてのキナゾリン誘導体 |
| ATE211134T1 (de) | 1996-03-05 | 2002-01-15 | 4-anilinochinazolin derivate | |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| JP3990061B2 (ja) * | 1998-01-05 | 2007-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | プリン誘導体および糖尿病の予防・治療剤としてのアデノシンａ２受容体拮抗剤 |
| CA2315736A1 (en) * | 1998-01-05 | 1999-07-15 | Eisai Co., Ltd. | Purine compounds and adenosine a2 receptor antagonist as preventive or therapeutic for diabetes mellitus |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| DK1553097T3 (da) | 1999-02-10 | 2010-12-13 | Astrazeneca Ab | Quinazolinderivat som angiogeneseinhibitor og mellemprodukter dertil |
| NZ516260A (en) | 1999-07-02 | 2004-08-27 | Eisai Co Ltd | Fused imidazole compounds and remedies for diabetes mellitus |
| ES2270867T3 (es) | 1999-09-23 | 2007-04-16 | Astrazeneca Ab | Compuestos de quinazolina terapeuticos. |
| NZ522074A (en) | 2000-05-31 | 2004-06-25 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| UA73993C2 (uk) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
| CA2410562A1 (en) | 2000-07-07 | 2002-01-31 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as angiogenesis inhibitors |
| JP2004502766A (ja) | 2000-07-07 | 2004-01-29 | アンギオジェン・ファーマシューティカルズ・リミテッド | 血管損傷剤としてのコルヒノール誘導体 |
| UA80295C2 (en) | 2002-09-06 | 2007-09-10 | Biogen Inc | Pyrazolopyridines and using the same |
| AU2004222387A1 (en) * | 2003-03-13 | 2004-09-30 | Synta Pharmaceuticals Corp. | Fused pyrrole compounds |
| WO2005032481A2 (en) | 2003-09-30 | 2005-04-14 | Scios Inc. | Quinazoline derivatives as medicaments |
| WO2006045828A1 (en) | 2004-10-29 | 2006-05-04 | Tibotec Pharmaceuticals Ltd. | Hiv inhibiting bicyclic pyrimidine derivatives |
| CR9465A (es) | 2005-03-25 | 2008-06-19 | Surface Logix Inc | Compuestos mejorados farmacocineticamente |
| GB0526246D0 (en) | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
| AR060358A1 (es) | 2006-04-06 | 2008-06-11 | Novartis Vaccines & Diagnostic | Quinazolinas para la inhibicion de pdk 1 |
| TWI389893B (zh) | 2007-07-06 | 2013-03-21 | Astellas Pharma Inc | 二（芳胺基）芳基化合物 |
| JPWO2009131173A1 (ja) | 2008-04-23 | 2011-08-18 | 協和発酵キリン株式会社 | ２−アミノキナゾリン誘導体 |
| US8252791B2 (en) | 2008-08-13 | 2012-08-28 | Jenrin Discovery, Inc. | Purine compounds as cannabinoid receptor blockers |
| WO2010056758A1 (en) | 2008-11-12 | 2010-05-20 | Yangbo Feng | Quinazoline derivatives as kinase inhibitors |
| JP5918693B2 (ja) | 2009-05-05 | 2016-05-18 | ダナ ファーバー キャンサー インスティテュート インコーポレイテッド | Ｅｇｆｒ阻害剤及び疾患の治療方法 |
| AU2010303343B2 (en) | 2009-10-07 | 2015-11-19 | Sloan-Kettering Institute For Cancer Research | Purine derivatives useful as HSP90 inhibitors |
| US7741330B1 (en) | 2009-10-12 | 2010-06-22 | Pharmacyclics, Inc. | Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase |
| WO2011079231A1 (en) | 2009-12-23 | 2011-06-30 | Gatekeeper Pharmaceutical, Inc. | Compounds that modulate egfr activity and methods for treating or preventing conditions therewith |
| WO2011106168A1 (en) | 2010-02-24 | 2011-09-01 | Dcam Pharma Inc | Purine compounds for treating autoimmune and demyelinating diseases |
| FR2959510B1 (fr) | 2010-04-28 | 2013-04-26 | Centre Nat Rech Scient | Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques |
| CN102260263A (zh) | 2010-05-26 | 2011-11-30 | 四川大学 | 一类二苯胺基嘌呤衍生物及制备方法和医药用途 |
| WO2012135801A1 (en) | 2011-04-01 | 2012-10-04 | University Of Utah Research Foundation | Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
| WO2013005157A1 (en) | 2011-07-05 | 2013-01-10 | Lupin Limited | Sulfone derivatives and their use as pkm2 modulators for the treatment of cancer |
| US8796289B2 (en) | 2011-07-19 | 2014-08-05 | Abbvie Inc. | Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases |
| EP2736895B1 (en) | 2011-07-27 | 2016-01-06 | Astrazeneca AB | 2-(2,4,5-substituted-anilino) pyrimidine derivatives as egfr modulators useful for treating cancer |
| WO2013032951A1 (en) | 2011-08-26 | 2013-03-07 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| EP3332785B1 (en) | 2011-09-14 | 2020-05-06 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| JP6353788B2 (ja) | 2012-01-13 | 2018-07-04 | エイシア バイオサイエンシーズ インコーポレイテッド | 抗がん剤としての複素環式化合物およびその使用 |
| WO2013118817A1 (ja) | 2012-02-07 | 2013-08-15 | 大鵬薬品工業株式会社 | キノリルピロロピリミジン化合物又はその塩 |
| WO2013130660A1 (en) | 2012-02-28 | 2013-09-06 | Amgen Inc. | Amides as pim inhibitors |
| DK2872491T3 (da) | 2012-07-11 | 2021-08-09 | Blueprint Medicines Corp | Inhibitorer af fibroblastvækstfaktorreceptoren |
| GB201216017D0 (en) | 2012-09-07 | 2012-10-24 | Cancer Rec Tech Ltd | Inhibitor compounds |
| TW201427958A (zh) | 2012-09-14 | 2014-07-16 | Univ Nat Yang Ming | 芳基胺取代之嘧啶及喹唑啉及其作為抗癌藥物之用途 |
| MX372736B (es) | 2012-09-28 | 2020-06-19 | Cancer Research Tech Ltd | Inhibidores de azaquinazolina de la proteina quinasa c atipica. |
| CN103864792B (zh) | 2012-12-12 | 2017-01-18 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的含氮并环类化合物 |
| CN103936742B (zh) | 2013-01-17 | 2017-05-03 | 程鹏 | 含嘌呤基的新型pi3k抑制剂及其制备方法和应用 |
| US9708326B2 (en) | 2013-02-25 | 2017-07-18 | Pharmacyclics Llc | Inhibitors of bruton's tyrosine kinase |
| WO2014135245A1 (en) | 2013-03-05 | 2014-09-12 | Merck Patent Gmbh | 9-(aryl or heteroaryl)-2-(pyrazolyl, pyrrolidinyl or cyclopentyl)aminopurine derivatives as anticancer agents |
| DK2964638T3 (en) | 2013-03-06 | 2017-10-30 | Astrazeneca Ab | QUINAZOLIN INHIBITORS TO ACTIVATE MUTANEOUS FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR |
| CN105164136B (zh) | 2013-05-06 | 2017-12-22 | 默克专利股份公司 | 作为激酶抑制剂的大环化合物 |
| CN103554038B (zh) | 2013-06-19 | 2015-10-14 | 云南大学 | 多卤代苯腈喹唑啉酮化合物及其制备方法和用途 |
| AU2014287016B2 (en) | 2013-07-11 | 2018-11-01 | Acea Biosciences Inc. | Pyrimidine derivatives as kinase inhibitors |
| WO2015022926A1 (ja) | 2013-08-12 | 2015-02-19 | 大鵬薬品工業株式会社 | 新規な縮合ピリミジン化合物又はその塩 |
| NZ718190A (en) * | 2013-08-23 | 2017-10-27 | Neupharma Inc | Substituted quinazolines for inhibiting kinase activity |
| US20160272645A1 (en) | 2013-10-18 | 2016-09-22 | Medivation Technologies, Inc. | Heterocyclic Compounds and Methods of Use |
| GB201404987D0 (en) | 2014-03-20 | 2014-05-07 | Redx Pharma Ltd | Compounds |
| RU2016148863A (ru) | 2014-05-14 | 2018-06-18 | Дзе Риджентс Оф Дзе Юниверсити Оф Колорадо, Э Боди Корпорейт | Гетероциклические гидроксамовые кислоты в качестве ингибиторов протеин-деацетилазы и двойных ингибиторов протеин-деацетилазы-протеин-киназы и способы их применения |
| CN104086551B (zh) | 2014-06-06 | 2016-09-21 | 人福医药集团股份公司 | 化合物及其制备方法和用途 |
| WO2015193740A2 (en) * | 2014-06-17 | 2015-12-23 | Acerta Pharma B.V. | Therapeutic combinations of a btk inhibitor, a pi3k inhibitor and/or a jak-2 inhibitor |
| CN105315283A (zh) | 2014-07-22 | 2016-02-10 | 成都贝斯凯瑞生物科技有限公司 | 一种Bruton酪氨酸激酶抑制剂 |
| CN106999494A (zh) | 2014-08-01 | 2017-08-01 | 药品循环有限公司 | 布鲁顿酪氨酸激酶的抑制剂 |
| BR112017014770A2 (pt) | 2015-01-08 | 2018-01-16 | Advinus Therapeutics Ltd | compostos bicíclicos, composições e aplicações médicas dos mesmos |
| CN105837576B (zh) | 2015-01-14 | 2019-03-26 | 湖北生物医药产业技术研究院有限公司 | Btk抑制剂 |
| EP3270694A4 (en) | 2015-02-17 | 2018-09-05 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| CN105777759B (zh) | 2016-04-29 | 2018-01-26 | 杭州和正医药有限公司 | 一种布鲁顿酪氨酸激酶抑制剂 |
| AU2017312561B2 (en) | 2016-08-15 | 2022-06-30 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
-
2017
- 2017-08-14 AU AU2017312561A patent/AU2017312561B2/en not_active Ceased
- 2017-08-14 JP JP2019508173A patent/JP7101165B2/ja not_active Expired - Fee Related
- 2017-08-14 EP EP17841949.5A patent/EP3497087B1/en active Active
- 2017-08-14 WO PCT/US2017/046819 patent/WO2018035061A1/en not_active Ceased
- 2017-08-14 CN CN201780063561.8A patent/CN109843858B/zh active Active
- 2017-08-14 US US15/676,852 patent/US10544106B2/en active Active
- 2017-08-14 CA CA3033370A patent/CA3033370A1/en active Pending
- 2017-08-14 EP EP21201676.0A patent/EP4006035B1/en active Active
-
2019
- 2019-12-04 US US16/702,936 patent/US11208388B2/en active Active
-
2021
- 2021-10-20 US US17/506,367 patent/US12018002B2/en active Active
-
2022
- 2022-02-07 JP JP2022017081A patent/JP2022058912A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019526550A5 (enExample) | ||
| AU2017312561A1 (en) | Certain chemical entities, compositions, and methods | |
| JP2016530274A5 (enExample) | ||
| US8785632B2 (en) | Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors | |
| US6489344B1 (en) | Inhibitors of glycogen synthase kinase 3 | |
| JP6847855B2 (ja) | Ｉｒａｋ４の阻害剤とｂｔｋの阻害剤の組み合わせ | |
| US8486950B2 (en) | Janus kinase inhibitor compounds and methods | |
| US7045519B2 (en) | Inhibitors of glycogen synthase kinase 3 | |
| TWI481608B (zh) | 作為ｊａｋ抑制劑之咪唑並吡啶衍生物 | |
| CN112771043B (zh) | 取代吡唑稠环类衍生物及其制备方法和应用 | |
| JP2021121628A (ja) | 治療活性化合物およびそれらの使用方法 | |
| RU2018138050A (ru) | Производные тиазолопиридина как агонисты gpr119 | |
| JP2016505529A5 (enExample) | ||
| AU2001295026A1 (en) | Inhibitors of glycogen synthase kinase 3 | |
| JP2018537408A5 (enExample) | ||
| KR20160079792A (ko) | 암 치료를 위한 raf 억제제로서의 1-(5-tert-부틸-2-아릴-피라졸-3-일)-3-[2-플루오로-4-[(3-옥소-4h-피리도[2,3-b]피라진-8-일)옥시]페닐]우레아 유도체 | |
| RU2014147191A (ru) | Амидопроизводные как блокаторы ttx-s | |
| JP2022017461A5 (enExample) | ||
| US20210000825A1 (en) | Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof | |
| SI2906546T1 (en) | Benzamides | |
| JP2020503302A5 (enExample) | ||
| US20250361223A1 (en) | Amide compounds and uses thereof | |
| KR20240046090A (ko) | 표적 단백질 분해를 위한 화합물 및 이의 용도 | |
| US20210355104A1 (en) | Adenosine receptor binding compounds | |
| JP2018516982A5 (ja) | 免疫療法用組み合わせ組成物 |